You are currently viewing a new version of our website. To view the old version click .

71 Results Found

  • Article
  • Open Access
10 Citations
3,349 Views
16 Pages

Effects of the Oral Angiotensin II Type 2 Receptor Agonist C21 in Sugen-Hypoxia Induced Pulmonary Hypertension in Rats

  • Göran Tornling,
  • Rohit Batta,
  • Dan Salvail,
  • Johan Raud and
  • Christopher P. Denton

Substantial evidence supports the involvement of the renin-angiotensin system in pulmonary hypertension (PH), and the angiotensin II type 2 receptor (AT2R) is known to exert tissue protective actions. The effect of the selective AT2R agonist C21 (als...

  • Article
  • Open Access
7 Citations
2,711 Views
13 Pages

29 September 2021

There is a paucity of epidemiologic data examining the relationship between pulmonary hypertension (PH) and diabetes. The aim of this study was to determine prevalence, incidence and associates of PH complicating type 2 diabetes. Data from 1430 parti...

  • Review
  • Open Access
12 Citations
16,539 Views
27 Pages

29 November 2022

Pulmonary arterial hypertension (PAH) is a progressive disease characterized by increased pulmonary vascular resistance (PVR), causing right ventricular hypertrophy and ultimately death from right heart failure. Heterozygous mutations in the bone mor...

  • Article
  • Open Access
2 Citations
2,209 Views
13 Pages

Resistin-like Molecule α and Pulmonary Vascular Remodeling: A Multi-Strain Murine Model of Antigen and Urban Ambient Particulate Matter Co-Exposure

  • Nedim Durmus,
  • Wen-Chi Chen,
  • Sung-Hyun Park,
  • Leigh M. Marsh,
  • Sophia Kwon,
  • Anna Nolan and
  • Gabriele Grunig

Pulmonary hypertension (PH) has a high mortality and few treatment options. Adaptive immune mediators of PH in mice challenged with antigen/particulate matter (antigen/PM) has been the focus of our prior work. We identified key roles of type-2- and t...

  • Case Report
  • Open Access
1 Citations
3,322 Views
14 Pages

COVID-19 Syndemic: Convergence of COVID-19, Pulmonary Aspergillosis (CAPA), Pulmonary Tuberculosis, Type 2 Diabetes Mellitus, and Arterial Hypertension

  • Jose Isaias Badillo-Almaraz,
  • Sergio Andres Cardenas-Cadena,
  • Fausto Daniel Gutierrez-Avella,
  • Pedro Javier Villegas-Medina,
  • Idalia Garza-Veloz,
  • Valentin Badillo Almaraz and
  • Margarita L Martinez-Fierro

Bacterial coinfections, which increase the severity of respiratory viral infections, are frequent causes of mortality in influenza pandemics but have not been well characterized in patients with Coronavirus disease 2019 (COVID-19). Moreover, the asso...

  • Article
  • Open Access
4 Citations
7,514 Views
20 Pages

NF-κB Activation Exacerbates, but Is not Required for Murine Bmpr2-Related Pulmonary Hypertension

  • Megha Talati,
  • Haitham Mutlak,
  • Kirk B. Lane,
  • Wei Han,
  • Anna Hemnes,
  • Outi Mutlak,
  • Tom Blackwell,
  • Rinat Zaynagetdinov,
  • Timothy S. Blackwell and
  • James West

30 May 2014

Aim: The present study investigates the role of NF-κB in Bmpr2-related pulmonary hypertension (PH) using a murine model of PH with inducible overexpression of a cytoplasmic tail Bmpr2 mutation. Methods and Results: Electrophoretic mobility shift assa...

  • Review
  • Open Access
11 Citations
7,205 Views
26 Pages

Myeloid-Derived Suppressor Cells and Pulmonary Hypertension

  • Andrew J. Bryant,
  • Borna Mehrad,
  • Todd M. Brusko,
  • James D. West and
  • Lyle L. Moldawer

Myeloid–derived suppressor cells (MDSCs) comprised a heterogeneous subset of bone marrow–derived myeloid cells, best studied in cancer research, that are increasingly implicated in the pathogenesis of pulmonary vascular remodeling and the...

  • Article
  • Open Access
1,203 Views
11 Pages

14 December 2023

An elevated estimated right ventricular systolic pressure (eRVSP) identified on echocardiography is present in one-third of individuals with type 2 diabetes, but its prognostic significance is unknown. To assess the relationship between eRVSP and mor...

  • Article
  • Open Access
8 Citations
3,111 Views
16 Pages

Long-Chain Acylcarnitines and Monounsaturated Fatty Acids Discriminate Heart Failure Patients According to Pulmonary Hypertension Status

  • Maxime Tremblay-Gravel,
  • Annik Fortier,
  • Cantin Baron,
  • Chloé David,
  • Pamela Mehanna,
  • Anique Ducharme,
  • Julie Hussin,
  • Qinghua Hu,
  • Jean-Claude Tardif and
  • Christine Des Rosiers
  • + 2 authors

26 March 2021

Defects in fatty acid (FA) utilization have been well described in group 1 pulmonary hypertension (PH) and in heart failure (HF), yet poorly studied in group 2 PH. This study was to assess whether the metabolomic profile of patients with pulmonary hy...

  • Article
  • Open Access
1,143 Views
11 Pages

Background: Hypertension is a significant public health issue, particularly in individuals with comorbidities such as COPD and T2DM, which exacerbate cardiovascular risk and impair quality of life. While physical activity is an effective intervention...

  • Article
  • Open Access
2 Citations
1,705 Views
10 Pages

30 September 2023

Blood gas analysis is part of the diagnostic work−up for pulmonary hypertension (PH). Although some studies have found that the partial pressure of carbon dioxide (PaCO2) is an independent marker of mortality in individuals with pulmonary arter...

  • Article
  • Open Access
4 Citations
2,441 Views
10 Pages

Association of Pulmonary Function Decline over Time with Longitudinal Change of Glycated Hemoglobin in Participants without Diabetes Mellitus

  • Wen-Hsien Lee,
  • Da-Wei Wu,
  • Ying-Chih Chen,
  • Yi-Hsueh Liu,
  • Wei-Sheng Liao,
  • Szu-Chia Chen,
  • Chih-Hsing Hung,
  • Chao-Hung Kuo and
  • Ho-Ming Su

30 September 2021

Pulmonary damage and function impairment were frequently noted in patients with diabetes mellitus (DM). However, the relationship between lung function and glycemic status in non-DM subjects was not well-known. Here, we evaluated the association of l...

  • Review
  • Open Access
26 Citations
5,181 Views
13 Pages

Pulmonary Vascular Complications in Hereditary Hemorrhagic Telangiectasia and the Underlying Pathophysiology

  • Sala Bofarid,
  • Anna E. Hosman,
  • Johannes J. Mager,
  • Repke J. Snijder and
  • Marco C. Post

In this review, we discuss the role of transforming growth factor-beta (TGF-β) in the development of pulmonary vascular disease (PVD), both pulmonary arteriovenous malformations (AVM) and pulmonary hypertension (PH), in hereditary hemorrhagic telangi...

  • Article
  • Open Access
4 Citations
2,514 Views
10 Pages

Central versus Peripheral CTEPH—Clinical and Hemodynamic Specifications

  • Monika Kaldararova,
  • Iveta Simkova,
  • Marcela Bohacekova,
  • Adriana Reptova,
  • Tereza Hlavata,
  • Jozef Pacak,
  • Jaroslav Lindner and
  • Pavel Jansa

27 October 2022

Background and Objectives: Chronic thromboembolic pulmonary hypertension (CTEPH) is a chronic progressive disease, resulting from persistent arterial obstruction combined with small-vessel remodeling. Central and peripheral CTEPH are distinguished, a...

  • Review
  • Open Access
24 Citations
13,328 Views
29 Pages

Novel Insights into the Therapeutic Potential of Lung-Targeted Gene Transfer in the Most Common Respiratory Diseases

  • Malik Bisserier,
  • Xiao-Qing Sun,
  • Shahood Fazal,
  • Irene C. Turnbull,
  • Sébastien Bonnet and
  • Lahouaria Hadri

12 March 2022

Over the past decades, a better understanding of the genetic and molecular alterations underlying several respiratory diseases has encouraged the development of new therapeutic strategies. Gene therapy offers new therapeutic alternatives for inherite...

  • Article
  • Open Access
17 Citations
3,994 Views
19 Pages

Central Role of Dendritic Cells in Pulmonary Arterial Hypertension in Human and Mice

  • Denise van Uden,
  • Thomas Koudstaal,
  • Jennifer A. C. van Hulst,
  • Ingrid M. Bergen,
  • Chelsea Gootjes,
  • Nicholas W. Morrell,
  • Geert van Loo,
  • Jan H. von der Thüsen,
  • Thierry P. P. van den Bosch and
  • Maria-Rosa Ghigna
  • + 5 authors

10 February 2021

The pathogenesis of idiopathic pulmonary arterial hypertension (IPAH) is not fully understood, but evidence is accumulating that immune dysfunction plays a significant role. We previously reported that 31-week-old Tnfaip3DNGR1-KO mice develop pulmona...

  • Review
  • Open Access
7,284 Views
27 Pages

Influence of Exercise on Oxygen Consumption, Pulmonary Ventilation, and Blood Gas Analyses in Individuals with Chronic Diseases

  • Mallikarjuna Korivi,
  • Mohan Krishna Ghanta,
  • Poojith Nuthalapati,
  • Nagabhishek Sirpu Natesh,
  • Jingwei Tang and
  • LVKS Bhaskar

7 August 2025

The increasing prevalence of chronic metabolic diseases poses a significant challenge in the modern world, impacting healthcare systems and individual life expectancy. The World Health Organization (WHO) recommends that older adults (65+ years) engag...

  • Review
  • Open Access
1 Citations
4,145 Views
15 Pages

Sotatercept selectively binds free activins and growth differentiation factors by reproducing the binding domain of the activin receptor type IIA (ACTRIIA). The sequester of activins blunts the downstream signaling pathway, resulting in the reactivat...

  • Article
  • Open Access
32 Citations
7,040 Views
18 Pages

Machine Learning Approaches to Identify Patient Comorbidities and Symptoms That Increased Risk of Mortality in COVID-19

  • Sakifa Aktar,
  • Ashis Talukder,
  • Md. Martuza Ahamad,
  • A. H. M. Kamal,
  • Jahidur Rahman Khan,
  • Md. Protikuzzaman,
  • Nasif Hossain,
  • A. K. M. Azad,
  • Julian M. W. Quinn and
  • Mathew A. Summers
  • + 3 authors

Providing appropriate care for people suffering from COVID-19, the disease caused by the pandemic SARS-CoV-2 virus, is a significant global challenge. Many individuals who become infected may have pre-existing conditions that may interact with COVID-...

  • Review
  • Open Access
18 Citations
6,927 Views
19 Pages

Pharmacology and Rationale for Seralutinib in the Treatment of Pulmonary Arterial Hypertension

  • Soni Savai Pullamsetti,
  • Ravikumar Sitapara,
  • Robin Osterhout,
  • Astrid Weiss,
  • Laura L. Carter,
  • Lawrence S. Zisman and
  • Ralph Theo Schermuly

10 August 2023

Pulmonary arterial hypertension (PAH) is a complex disorder characterized by vascular remodeling and a consequent increase in pulmonary vascular resistance. The histologic hallmarks of PAH include plexiform and neointimal lesions of the pulmonary art...

  • Article
  • Open Access
1,520 Views
16 Pages

A Retrospective Evaluation of the Cardiometabolic Profile of Patients with COPD-Related Type 2 Respiratory Failure in the Intensive Care Unit

  • Oral Mentes,
  • Deniz Celik,
  • Murat Yildiz,
  • Kerem Ensarioglu,
  • Mustafa Ozgur Cirik,
  • Tulay Tuncer Peker,
  • Fatma Canbay,
  • Guler Eraslan Doganay and
  • Abdullah Kahraman

11 April 2025

Background and Objectives: Chronic obstructive pulmonary disease (COPD) is a notable cause of morbidity and mortality worldwide and can become complicated by Type 2 respiratory failure. This study aimed to analyze the cardiological and metabolic como...

  • Article
  • Open Access
1 Citations
369 Views
23 Pages

Fenofibrate as a Modulator of the Renin–Angiotensin System in Su/Hx-Induced Pulmonary Arterial Hypertension

  • Karla M. Rada-Pascual,
  • Alejandra M. Zúniga-Muñoz,
  • Yamnia Q. Alvarez-Alvarez,
  • Leonardo Del Valle-Mondragón,
  • Ivan Rubio-Gayosso,
  • Constanza E. Martínez-Olivares,
  • Rogelio Hernández-Pando,
  • Horacio Osorio-Alonso,
  • José L. Sánchez-Gloria and
  • Pedro L. Flores
  • + 4 authors

22 October 2025

We evaluated the effects of fenofibrate (FF) in a SU5416/hypoxia model of pulmonary arterial hypertension (PAH) with a specific focus on its influence on the renin–angiotensin system (RAS). We assessed right ventricular systolic pressure (RVSP)...

  • Communication
  • Open Access
8 Citations
8,640 Views
12 Pages

PDE5 Inhibitors in Type 2 Diabetes Cardiovascular Complications

  • Federica Barbagallo,
  • Federica Campolo,
  • Edoardo Franceschini,
  • Elena Crecca,
  • Riccardo Pofi,
  • Andrea M. Isidori and
  • Mary Anna Venneri

29 October 2020

Pharmacological inhibition of Phosphodiesterase type 5 (PDE5) proved its efficacy treating several pathological conditions, such as erectile dysfunction and pulmonary hypertension. Nowadays, its benefits on cardiovascular diseases are well documented...

  • Review
  • Open Access
5 Citations
5,732 Views
9 Pages

Prostacyclin Regulation of Allergic Inflammation

  • Kunj Patel and
  • R. Stokes Peebles

Prostacyclin is a metabolic product of the cyclooxygenase pathway that is constitutively expressed and can be induced during inflammatory conditions. While prostacyclin and its analogs have historically been considered effective vasodilators and used...

  • Review
  • Open Access
44 Citations
16,607 Views
23 Pages

19 February 2020

Pulmonary hypertension (PH) is a debilitating progressive disease characterized by increased pulmonary arterial pressures, leading to right ventricular (RV) failure, heart failure and, eventually, death. Based on the underlying conditions, PH patient...

  • Article
  • Open Access
50 Citations
7,439 Views
21 Pages

12 September 2018

Right ventricular failure (RVF) remains the leading cause of death in pulmonary arterial hypertension (PAH). We investigated the transcriptomic signature of RVF in hemodynamically well-phenotyped monocrotaline (MCT)-treated, male, Sprague-Dawley rats...

  • Review
  • Open Access
1,130 Views
11 Pages

The Impact of Insulin Resistance on Lung Volume Through Right Ventricular Dysfunction in Diabetic Patients—Literature Review

  • Daniel Radu,
  • Oana-Andreea Parlițeanu,
  • Andra-Elena Nica,
  • Cristiana Voineag,
  • Octavian-Sabin Alexe,
  • Alexandra Maria Cristea,
  • Livia Georgescu,
  • Roxana Maria Nemeș,
  • Andreea Taisia Tiron and
  • Alexandra Floriana Nemeș

1 August 2025

Insulin resistance (IR), a core component in the development of type 2 diabetes mellitus (T2DM), is increasingly recognized for its role in cardiovascular and pulmonary complications. This review explores the relationship between IR, right ventricula...

  • Article
  • Open Access
2,562 Views
20 Pages

16 August 2024

Background and Objectives: This study aims to analyze survival in peritoneal and hemodialysis patients using chest radiography and biochemical parameters, determine common dialysis etiologies and causes of death, reveal prognostic factors, and contri...

  • Article
  • Open Access
3 Citations
2,261 Views
16 Pages

20 December 2022

Chinese herbal medicine plays an important role in regulating the nutritional metabolism of poultry and maintaining or improving normal physiological functions and animal health. The present study investigated the effects of dietary supplementation w...

  • Article
  • Open Access
13 Citations
2,794 Views
14 Pages

Diastolic versus Systolic Left Ventricular Dysfunction as Independent Predictors for Unfavorable Postoperative Evolution in Patients with Aortic Regurgitation Undergoing Aortic Valve Replacement

  • Luminita Iliuta,
  • Andreea Gabriella Andronesi,
  • Camelia Cristina Diaconu,
  • Horatiu Moldovan,
  • Marius Rac-Albu and
  • Madalina-Elena Rac-Albu

19 November 2022

Background and Objectives: Chronic severe aortic valve disease is associated with important changes in left ventricle (LV) performance associated with eccentric or concentric LV hypertrophy. We aimed to assess the immediate prognostic implications of...

  • Article
  • Open Access
14 Citations
4,314 Views
24 Pages

Andrographolide Attenuates Established Pulmonary Hypertension via Rescue of Vascular Remodeling

  • Xiaowei Nie,
  • Chenyou Shen,
  • Jianxin Tan,
  • Xusheng Yang,
  • Wei Wang,
  • Youai Dai,
  • Haijian Sun,
  • Zhiyuan Wu and
  • Jingyu Chen

30 November 2021

Pulmonary hypertension (PH) is characterized by vascular remodeling caused by marked proliferation of pulmonary artery smooth muscle cells (PASMCs). Andrographolide (ANDRO) is a potent anti-inflammatory agent which possesses antioxidant, and has anti...

  • Review
  • Open Access
46 Citations
6,917 Views
14 Pages

Sleep Apnea and Cardiovascular Risk in Patients with Prediabetes and Type 2 Diabetes

  • Stavroula A. Paschou,
  • Evanthia Bletsa,
  • Katerina Saltiki,
  • Paraskevi Kazakou,
  • Kanella Kantreva,
  • Paraskevi Katsaounou,
  • Nikoletta Rovina,
  • Georgia Trakada,
  • Petros Bakakos and
  • Charalambos V. Vlachopoulos
  • + 1 author

24 November 2022

Obstructive sleep apnea (OSA) is a common but largely undiagnosed clinical condition, which is turning into a serious public health issue. Of note is that its prevalence is gradually increasing in parallel with the obesity and type 2 diabetes mellitu...

  • Communication
  • Open Access
11 Citations
2,410 Views
9 Pages

Mitochondrial Respiration in Peripheral Blood Mononuclear Cells Negatively Correlates with Disease Severity in Pulmonary Arterial Hypertension

  • Natascha Sommer,
  • Finn Fabian Theine,
  • Oleg Pak,
  • Khodr Tello,
  • Manuel Richter,
  • Henning Gall,
  • Jochen Wilhelm,
  • Rajkumar Savai,
  • Norbert Weissmann and
  • Werner Seeger
  • + 2 authors

16 July 2022

Mitochondrial and immune cell dysfunction contributes to the development of pulmonary arterial hypertension (PAH). We thus aimed to investigate mitochondrial respiration and mitochondrial gene expression patterns in the peripheral blood mononuclear c...

  • Review
  • Open Access
26 Citations
4,401 Views
23 Pages

Mitochondrial proteins carrying iron-sulfur (Fe-S) clusters are involved in essential cellular pathways such as oxidative phosphorylation, lipoic acid synthesis, and iron metabolism. NFU1, BOLA3, IBA57, ISCA2, and ISCA1 are involved in the last steps...

  • Article
  • Open Access
41 Citations
97,814 Views
11 Pages

Effect of Cheese Intake on Cardiovascular Diseases and Cardiovascular Biomarkers

  • Meng-Jin Hu,
  • Jiang-Shan Tan,
  • Xiao-Jin Gao,
  • Jin-Gang Yang and
  • Yue-Jin Yang

18 July 2022

Background: A growing number of cohort studies revealed an inverse association between cheese intake and cardiovascular diseases, yet the causal relationship is unclear. Objective: To assess the causal relationship between cheese intake, and cardiova...

  • Review
  • Open Access
60 Citations
7,699 Views
18 Pages

Risk Factors for Periprosthetic Joint Infection after Primary Total Knee Arthroplasty

  • Emerito Carlos Rodriguez-Merchan and
  • Alberto D. Delgado-Martinez

18 October 2022

Periprosthetic joint infection (PJI) is a major adverse event of primary total knee arthroplasty (TKA) from the patient’s perspective, and it is also costly for health care systems. In 2010, the reported incidence of PJI in the first 2 years af...

  • Article
  • Open Access
23 Citations
6,332 Views
17 Pages

Cannabidiol Improves Antioxidant Capacity and Reduces Inflammation in the Lungs of Rats with Monocrotaline-Induced Pulmonary Hypertension

  • Anna Krzyżewska,
  • Marta Baranowska-Kuczko,
  • Anna Jastrząb,
  • Irena Kasacka and
  • Hanna Kozłowska

Cannabidiol (CBD) is a plant-derived compound with antioxidant and anti-inflammatory properties. Pulmonary hypertension (PH) is still an incurable disease. CBD has been suggested to ameliorate monocrotaline (MCT)-induced PH, including reduction in ri...

  • Article
  • Open Access
17 Citations
6,268 Views
16 Pages

Redistribution of Extracellular Superoxide Dismutase Causes Neonatal Pulmonary Vascular Remodeling and PH but Protects Against Experimental Bronchopulmonary Dysplasia

  • Laurie G. Sherlock,
  • Ashley Trumpie,
  • Laura Hernandez-Lagunas,
  • Sarah McKenna,
  • Susan Fisher,
  • Russell Bowler,
  • Clyde J. Wright,
  • Cassidy Delaney and
  • Eva Nozik-Grayck

Background: A naturally occurring single nucleotide polymorphism (SNP), (R213G), in extracellular superoxide dismutase (SOD3), decreases SOD3 matrix binding affinity. Humans and mature mice expressing the R213G SNP exhibit increased cardiovascular di...

  • Article
  • Open Access
1 Citations
1,941 Views
14 Pages

Intrapulmonary T Cells Are Sufficient for Schistosoma-Induced Pulmonary Hypertension

  • Dara C. Fonseca Balladares,
  • Biruk Kassa,
  • Claudia Mickael,
  • Rahul Kumar,
  • Kevin Nolan,
  • Thais C. F. Menezes,
  • Michael H. Lee,
  • Anthony M. Lau-Xiao,
  • Ari B. Molofsky and
  • Elina Wells
  • + 1 author

24 August 2024

Background: Schistosomiasis is a parasitic infection that can cause pulmonary hypertension (PH). Th2 CD4 T cells are necessary for experimental Schistosoma-PH. However, if T cells migrate to the lung to initiate, the localized inflammation that drive...

  • Article
  • Open Access
2,494 Views
10 Pages

Longitudinal Assessment of Multimorbidity Medication Patterns among Smokers in the COPDGene Cohort

  • Yisha Li,
  • Sarah J. Schmiege,
  • Heather Anderson,
  • Nicole E. Richmond,
  • Kendra A. Young,
  • John E. Hokanson,
  • Stephen I. Rennard,
  • Tessa L. Crume,
  • Erin Austin and
  • Katherine A. Pratte
  • + 2 authors

Background and objectives: Chronic obstructive pulmonary disease (COPD) is usually comorbid with other chronic diseases. We aimed to assess the multimorbidity medication patterns and explore if the patterns are similar for phase 1 (P1) and 5-year fol...

  • Review
  • Open Access
16 Citations
7,294 Views
28 Pages

We live and to do so we must breathe and eat, so are we a combination of what we eat and breathe? Here, we will consider this question, and the role in this respect of the AMP-activated protein kinase (AMPK). Emerging evidence suggests that AMPK faci...

  • Review
  • Open Access
14 Citations
5,395 Views
16 Pages

Microbiota and Its Impact on the Immune System in COVID-19—A Narrative Review

  • Marzena Jabczyk,
  • Justyna Nowak,
  • Bartosz Hudzik and
  • Barbara Zubelewicz-Szkodzińska

30 September 2021

The microbiota is of interest for the development of a therapeutic strategy against SARS-CoV-2 coronavirus disease 2019 (COVID-19) due to its impact on the host immune system. Proven communications of the gut microbiota with the pulmonary microbiota...

  • Review
  • Open Access
35 Citations
5,518 Views
12 Pages

The Role of Endothelium in COVID-19

  • Mihaela Ionescu,
  • Anca Pantea Stoian,
  • Manfredi Rizzo,
  • Dragos Serban,
  • Domenico Nuzzo,
  • Laura Mazilu,
  • Andra Iulia Suceveanu,
  • Ana Maria Dascalu and
  • Irinel Raluca Parepa

3 November 2021

The 2019 novel coronavirus, known as severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) or coronavirus disease 2019 (COVID-19), is causing a global pandemic. The virus primarily affects the upper and lower respiratory tracts and raises the...

  • Article
  • Open Access
987 Views
11 Pages

Hemodynamic and Genetic Associations with the Risk of Idiopathic Pulmonary Arterial Hypertension Development in an Ethnic Cohort of Kazakhs

  • Dana Taizhanova,
  • Togzhan Nurpissova,
  • Gulshara Abildinova,
  • Tamilla Martynyuk,
  • Nazgul Kulmyrzayeva and
  • Elena Zholdybayeva

28 November 2024

Introduction: Idiopathic pulmonary arterial hypertension (IPAH) is a progressive and fatal disease. The aim of this study was to evaluate the association of polymorphism of the type 2 bone morphogenetic protein receptor gene (BMPR2) with the risk of...

  • Article
  • Open Access
3 Citations
3,219 Views
20 Pages

A Story of PA/BSA and Biomarkers to Diagnose Pulmonary Hypertension in Patients with Severe Aortic Valve Stenosis—The Rise of IGF-BP2 and GDF-15

  • Joseph Kletzer,
  • Stefan Hecht,
  • Susanne Ramsauer,
  • Bernhard Scharinger,
  • Reinhard Kaufmann,
  • Jürgen Kammler,
  • Jörg Kellermair,
  • Kaveh Akbari,
  • Hermann Blessberger and
  • Clemens Steinwender
  • + 4 authors

(1) Background: Currently, echocardiography is the primary non-invasive diagnostic method used to screen patients with severe aortic valve stenosis (AS) for pulmonary hypertension (PH) by estimating systolic pulmonary artery pressure (sPAP). Other ra...

  • Article
  • Open Access
2 Citations
844 Views
9 Pages

Comorbidity in Patients Undergoing Surgery for Lung Cancer. Do We Have an Adequate Tool to Assess It?

  • Marta Lembicz,
  • Piotr Gabryel,
  • Beata Brajer-Luftmann,
  • Wojciech Dyszkiewicz and
  • Halina Batura-Gabryel

Introduction: In the recent years comorbidity has been discussed as a factor affecting therapeutic decisions, the course of treatment, and prognosis of patients with lung cancer. The aim of the study was 1. to evaluate the occurrence of comorbidities...

  • Article
  • Open Access
1 Citations
2,992 Views
12 Pages

BMPR2 Variants Underlie Nonsyndromic Oligodontia

  • Jinglei Zheng,
  • Haochen Liu,
  • Miao Yu,
  • Bichen Lin,
  • Kai Sun,
  • Hangbo Liu,
  • Hailan Feng,
  • Yang Liu and
  • Dong Han

13 January 2023

Oligodontia manifests as a congenital reduction in the number of permanent teeth. Despite the major efforts that have been made, the genetic etiology of oligodontia remains largely unknown. Bone morphogenetic protein receptor type 2 (BMPR2) variants...

  • Article
  • Open Access
2 Citations
2,622 Views
9 Pages

Predictors of Acute Encephalopathy in Patients with COVID-19

  • Oleg I. Vinogradov,
  • Tatyana K. Ogarkova,
  • Kamila V. Shamtieva,
  • Pavel V. Alexandrov,
  • Astanda V. Mushba,
  • Daria S. Kanshina,
  • Daria V. Yakovleva,
  • Maria A. Surma,
  • Ilia S. Nikolaev and
  • Nadezhda Kh. Gorst

20 October 2021

Introduction: The majority of patients with severe COVID-19 suffer from delirium as the main sign of encephalopathy associated with this viral infection. The aim of this study was to identify early markers of the development of this condition. Materi...

  • Communication
  • Open Access
2 Citations
2,994 Views
5 Pages

COVID-19 Pneumonia in Fully Vaccinated Adults during the Dominance of the Omicron Sublineages BA.1.1 and BA.2 in Mexico

  • Efrén Murillo-Zamora,
  • Xóchitl Trujillo,
  • Miguel Huerta,
  • Mónica Riós-Silva,
  • José Guzmán-Esquivel,
  • Jaime Alberto Bricio-Barrios,
  • Oliver Mendoza-Cano and
  • Agustin Lugo-Radillo

19 August 2022

Background and Objectives: A nationwide retrospective cohort study was conducted to evaluate the factors associated with the risk of laboratory-confirmed coronavirus disease 2019 (COVID-19)-related pneumonia in fully vaccinated adults during the domi...

  • Article
  • Open Access
1,699 Views
13 Pages

Gender-Based Differences in COPD Patients with Type 2 Respiratory Failure—Impact on Clinical Practice

  • Tarkan Ozdemir,
  • Murat Yıldız,
  • Maşide Arı,
  • Emrah Arı,
  • Güler Eraslan Doğanay,
  • Mustafa Özgür Cırık,
  • Melek Doğancı,
  • Çiğdem Özdilekcan,
  • Derya Kızılgöz and
  • Yusuf Tuğrul Şipit

25 March 2025

Background and Objectives: To contribute to clinical practice by identifying gender-based differences in patients diagnosed with chronic obstructive pulmonary disease (COPD) who are monitored in the intensive care unit due to type 2 respiratory failu...

of 2